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Although the critical role for epigenetic mechanisms in development and cell differentiation has long been
appreciated, recent evidence reveals that these mechanisms are also employed in postmitotic neurons as
a means of consolidating and stabilizing cognitive-behavioral memories. In this review, we discuss evidence
for an ‘‘epigenetic code’’ in the central nervous system that mediates synaptic plasticity, learning, and
memory.We consider how specific epigenetic changes are regulated andmay interact with each other during
memory formation and how these changes manifest functionally at the cellular and circuit levels. We also
describe a central role for mitogen-activated protein kinases in controlling chromatin signaling in plasticity
and memory. Finally, we consider how aberrant epigenetic modifications may lead to cognitive disorders
that affect learning and memory, and we review the therapeutic potential of epigenetic treatments for the
amelioration of these conditions.Introduction
Biologists have long recognized the conceptual parallels
between cellular development and cognitive-behavioral memory
formation (Marcus et al., 1994). Both cellular development and
memory formation rely on transient environmental signals to
trigger lasting, even lifelong, cellular changes. There is a clear
analogy between developmental ‘‘memory,’’ where cell pheno-
types and properties are triggered during development and
stored and manifest for a lifetime, and cognitive-behavioral
memory, where information is acquired through experience
and is subsequently available for long-term recollection.
Investigation of the precise molecular mechanisms in both
cellular development and memory has increased over the
past two decades, and an interesting new understanding has
emerged: developmental regulation of cell division and cell
terminal differentiation involves many of the same molecular
signaling cascades that are employed in learning and memory
storage. Therefore, cellular development and cognitive memory
processes are not just analogous but are homologous at the
molecular level.
There are several specific known examples in mammalian
systems that substantiate this generalization. One example is
the role of developmental growth factors such as BDNF and
reelin in triggering plasticity and long-term behavioral memories
in the adult CNS (Bekinschtein et al., 2007; Herz and Chen, 2006;
Patterson et al., 1996; Rattiner et al., 2004; Weeber et al., 2002).
Also, the prototypic signal transduction cascades that regulate
cell division and differentiation developmentally (the mitogen-
activated protein kinases [MAPKs]) are a central and conserved
signaling pathway subserving adult synaptic plasticity and
memory (Sharma and Carew, 2004; Sweatt, 2001; Thomas and
Huganir, 2004). Finally and perhaps most strikingly, a series of
studies over the last decade has demonstrated a role for epige-
netic molecular mechanisms, specifically DNA methylation,
chromatin modification, and prion-like mechanisms, in gener-
ating and maintaining experience-driven behavioral change in
young and old animals (Levenson and Sweatt, 2006).Here we provide an overview of recent findings that suggest
that epigenetic mechanisms, comprising an epigenetic code,
are utilized in long-term memory formation in the adult CNS.
We also briefly illustrate the parallel utilization of cellular signal
transduction cascades in both development andmemory forma-
tion, focusing on MAPK signaling and its role in controlling
learning and memory-associated gene expression. We also
discuss the emerging role of the MAPK cascade in regulating
memory-associated epigenetic modifications in the CNS. We
then present several possibilities as to how an epigenetic code
might manifest itself to drive functional changes in neurons
within a memory-encoding neural circuit, describing results
implicating gene targets such as BDNF in this process. Finally,
we discuss the potential relevance of these studies to the human
condition, describing examples of what might be considered
‘‘epigenetic’’ disorders of cognitive function and the idea that
epigenetic mechanisms represent a new therapeutic target for
disorders of learning, memory, and drug abuse.
Cracking the Epigenetic Code
The Histone Code and Its Role in Learning and Memory
Within a cell nucleus, 147 bp of DNA is wrapped tightly around an
octamer of histone proteins (two each of H2A, H2B, H3, and H4)
to form the basic unit of chromatin called the nucleosome. Each
histone protein is composed of a central globular domain and an
N-terminal tail that contains multiple sites for potential modifica-
tions, including acetylation, phosphorylation, methylation, ubiq-
uitination, and ADP-ribosylation (see Figure 1). Each of these
marks is bidirectionally catalyzed or removed by a specific set
of enzymes (Strahl and Allis, 2000). Thus, histone acetyltrans-
ferases (HATs) catalyze the transfer of acetyl groups to histone
proteins, whereas histone deacetylases (HDACs) cause the
removal of acetyl groups. Likewise, histone methylation is initi-
ated by histone methyltransferases (HMTs) such as G9a,
whereas histone demethylases (HDMs) such as LSD1 remove
methylation marks (Shi et al., 2004; Tachibana et al., 2001). Inter-
estingly, a number of histone sites can undergo dimethylation orNeuron 70, June 9, 2011 ª2011 Elsevier Inc. 813
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Figure 1. Dynamic Regulation of Histone Modifications Directs Transcriptional Activity
(A) Individual residues on histone tails undergo a number of unique modifications, including acetylation, phosphorylation, and mono-, di-, and trimethylation,
surrounding the transcription start site (TSS) for a given gene. These modifications in turn correlate with transcriptional repression (top), in which DNA is tightly
condensed on the nucleosome and therefore inaccessible, or transcriptional activation (bottom), in which transcription factors (TF) or RNA polymerase II (RNAP II)
can access the underlying DNA to promote gene expression. The specific epigenetic marks listed correlate with transcriptional activation or repression, although
this list is by no means exhaustive.
(B) Expanded view of individual modifications on the tail of histone H3. See Main Text for details and acronyms. The concept of a histone ‘‘code’’ suggests that
individual marks interact with each other to form a combinatorial outcome. In this case, methylation at lysine 9 on H3 (a mark of transcriptional repression) and
phosphorylationat serine 10onH3 represseachother,whereasphosphorylationat serine10enhancesacetylationon lysine14 (amarkof transcriptional activation).
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2007). Finally, phosphorylation of serine or threonine residues on
histone tails can be accomplished by a broad range of nuclear
kinases, such as MSK-1, and can be dephosphorylated by
protein phosphatases such as protein phosphatase 1 (PP1)
(Brami-Cherrier et al., 2009; Koshibu et al., 2009).814 Neuron 70, June 9, 2011 ª2011 Elsevier Inc.Importantly, histone modifications are capable of being both
gene specific within the genome and site specific within a given
chromatin particle, meaning that they are in an ideal position to
selectively influence gene expression. Site-specific modifica-
tions are known to directly alter chromatin state and transcription
through a number of mechanisms. For example, acetylation of
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the charged attraction between a histone tail and DNA, thereby
increasing access of transcription factors or RNA polymerase
to DNA sites. Additionally, site-specific acetylation of a histone
tail enables transcription factors that contain a bromodomain
to bind to the histone and initiate chromatin remodeling (Dyson
et al., 2001). Likewise, methylated lysines are bound by proteins
with a chromodomain, although the affinity of these proteins for
their respective modification is highly dependent on the overall
context and presence of other modifications (Scharf and Imhof,
2010). Moreover, while some modifications such as histone
acetylation or phosphorylation are generally associated with
transcriptional activation, others are more closely correlated
with transcriptional repression (Barski et al., 2007; Wang et al.,
2008).
Given that histone proteins can be modified at a number of
sites, this raises the possibility that specific modifications could
work together as a sort of ‘‘code,’’ which would ultimately dictate
whether a specific gene was transcribed. This hypothesis, first
formalized nearly a decade ago (Jenuwein and Allis, 2001; Strahl
and Allis, 2000; Turner, 2000) and more recently supported
experimentally (Campos and Reinberg, 2009), suggests that
certain combinations of modifications will lead to transcriptional
activation, whereas others would lead to transcriptional re-
pression. Indeed, analysis of histone modifications across the
human genome usingChIP-Seq (chromatin immunoprecipitation
sequencing) has demonstrated that a specific combination of 17
modifications tended to co-occur at the level of the individual
nucleosome and was associated with increased gene expres-
sion (Wang et al., 2008). Importantly, this group of modifications
was observed at thousands of gene promoters, indicating that it
is a relatively general mechanism by which histonemodifications
may alter gene transcription (Wang et al., 2008). Although small
groups of histone modifications tend to occur together, these
modifications are only correlated with (rather than explicitly
predictive of) increased gene expression. Moreover, exact com-
binations of modifications across a nucleosome are seldom
repeated at different genes, indicating complex and gene-
specific regulation of histone modifications. Thus, the histone
code hypothesis has since been modified to consider both the
context of a specific modification and the final outcome (Lee
et al., 2010; Turner, 2007), in which the histone code is consid-
ered to be the ‘‘language’’ that controls gene expression rather
than an explicit combination of modifications that always
generate an identical response.
Theoretically, the incorporation of multiple histone modifica-
tions into a code could occur in a number of ways. For instance,
a specific modification may recruit other histone-modifying
enzymes that either repress or facilitate nearby marks (Fig-
ure 1B). This appears to be the case with phosphorylation at
Ser10 on H3, which both represses methylation at lysine 9 and
encourages acetylation at lysine 14 (Cheung et al., 2000; Fischle
et al., 2005). Interestingly, this type of interaction may occur
between different histone tails, as well as on the same tail (Zippo
et al., 2009). Another possibility is that although certain marks
may act as transcriptional repressors under some cases, they
may facilitate transcription in the presence of another mark on
the same histone tail. This would explain why a number ofhistone modifications have been associated with both transcrip-
tional activation and transcriptional repression and why sets of
marks that are both independently correlatedwith transcriptional
activation do not necessarily always occur together (Barski et al.,
2007). Yet another means by which specific histone modifica-
tions could combine to produce a unique epigenetic signature
is via the inherent kinetics underlying each reaction. Histone
acetylation and phosphorylation are likely reversed very rapidly,
whereas histone methylation may persist for longer periods of
time. This would allow these mechanisms to synergistically
control gene expression across unique time courses despite
having no direct interactions.
Overwhelming evidence indicates that histone modifications
in the CNS are essential components of memory formation and
consolidation. Indeed, multiple types of behavioral experiences
are capable of inducing histone modifications in several brain
regions (Bredy et al., 2007; Chwang et al., 2007; Fischer et al.,
2007; Gupta et al., 2010; Koshibu et al., 2009; Levenson et al.,
2004; Lubin and Sweatt, 2007; Peleg et al., 2010; Swank and
Sweatt, 2001). For example, contextual fear conditioning,
a hippocampus-dependent form of memory, coincides with
increases in H3K9 dimethylation, H3K4 trimethylation, H3S10
phosphorylation, and H3S10/H3K14 phosphoacetylation in the
CA1 region of the hippocampus (Chwang et al., 2006; Gupta
et al., 2010). Moreover, contextual fear conditioning coincides
with enhanced acetylation at multiple sites on the tails of H3
and H4, including H3K9, H3K14, H4K5, H4K8, and H4K12 in
the hippocampus (Peleg et al., 2010). None of these changes
occur in control animals that are exposed to the same context
but receive no fear conditioning, indicating that these modi-
fications are specific to associative learning. Importantly, inter-
ference with the molecular machinery that regulates histone
acetylation, phosphorylation, and methylation disrupts associa-
tive learning and long-term potentiation (LTP; a cellular correlate
of memory) (Alarco´n et al., 2004; Chwang et al., 2007; Fischer
et al., 2007; Gupta et al., 2010; Korzus et al., 2004; Koshibu
et al., 2009; Levenson et al., 2004; Vecsey et al., 2007). Specifi-
cally, upregulating histone acetylation using HDAC inhibitors
enhances memory formation and LTP (Levenson et al., 2004),
whereas genetic mutations in CREB binding protein (CBP),
a known HAT, disrupts memory formation and LTP (Alarco´n
et al., 2004). Likewise, mice with deletion of a specific HDAC
(HDAC2) display enhanced fear conditioning and hippocampal
LTP, whereas overexpression of HDAC2 in the hippocampus
impairs memory and blunts LTP (Guan et al., 2009). Similarly
for histone phosphorylation, inhibition of nuclear PP1, which is
implicated in the removal of histone phosphorylation marks,
results in improved long-term memory (Koshibu et al., 2009),
whereas genetic deletion of specific histone methyltransferases
impairs memory formation (Gupta et al., 2010).
Overall, these modifications are consistent with the involve-
ment of a ‘‘histone code’’ in learning and memory, in which
specific sets of changes are produced in response to specific
types of behavioral experiences, and these modifications are
necessary for memory formation and/or consolidation. However,
in the context of learning and memory, it appears that it is the
combination of histone modifications, rather than the sum of
individual modifications, that produces unique changes in geneNeuron 70, June 9, 2011 ª2011 Elsevier Inc. 815
Figure 2. DNA Methylation Status Affects Gene Transcription
A number of plasticity-related genes in the brain possess large CpG islands
within the gene promoter region. Each CpG dinucleotide in the DNA sequence
can undergo methylation by DNA methyltransferases (DNMTs), resulting in
hemimethylation and/or double-stranded DNA methylation. Proteins with
methyl-binding domains bind to methylated DNA and associate with other
cofactors, such as HDACs or transcription factors like CREB, to alter gene
expression. It is presently unclear whether the specific combination of CpG
methylation marks constitutes a ‘‘code’’ for unique outcomes or whether the
overall or average density of methylation is a larger determinant of transcrip-
tional efficacy.
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co-occurrence of acetylation at H3K9, H3K14, H4K5, H4K8,
and H4K12 in the hippocampus following fear conditioning is
associated with changes in the transcription of hundreds of
genes in young mice (Peleg et al., 2010). In contrast, elderly
mice that lack acetylation only at H4K12 following fear condi-
tioning manifest learning deficits and show almost no condi-
tioning-induced changes in gene expression. This suggests
that a specific combination of histonemodifications is necessary
to initiate learning-related gene expression programs. Con-
sistent with this hypothesis, treatment with an HDAC inhibitor
selectively restored H4K12 acetylation, enabled the condi-
tioning-induced changes in gene expression, and improved
fear memory formation (Peleg et al., 2010).
The DNA Methylation Code and Its Role in Learning and
Memory
DNAmethylation, or the addition of amethyl group to the 50 posi-
tion on a cytosine pyrimidine ring, can also occur at multiple sites
within a gene. However, methylation is generally limited to cyto-
sine nucleotides followed by guanine nucleotides, or so-called
CpG sites. These sites, though underrepresented throughout
the genome, are occasionally clustered in CpG ‘‘islands.’’ Inter-
estingly, CpG islands tend to exist in the promoter regions of
active genes, suggesting the ability to control transcription.
DNA methylation is catalyzed by two groups of enzymes, known
as DNA methyltransferases (DNMTs). The first group, de novo
DNMTs, methylates ‘‘naked’’ or nonmethylated cytosines on
either DNA strand. The second group, maintenance DNMTs,
recognizes hemimethylated DNA and attaches a methyl group
to the complementary cytosine base. DNMTs ensure self-
perpetuating DNAmethylation in the face of ongoing passive de-
methylation, allowing for persistent chemical modification
throughout the lifetime of a single cell (Day and Sweatt, 2010a).
Like histone modifications, DNA methylation may constitute
an epigenetic code (Turner, 2007), although this idea is more
recent and has been less fully explored. Clearly, methylation at
promoter regions is capable of altering transcription due to the
affinity of certain proteins for methylated cytosine (methyl-
binding domain proteins, or MBDs). The prototypical example
of anMBD is MeCP2, which is mutated in the neurodevelopmen-
tal disorder Rett syndrome and dramatically affects synaptic
plasticity in the hippocampus and memory formation (Amir
et al., 1999; Chao et al., 2007; Moretti et al., 2006). Mechanisti-
cally, MeCP2 is capable of recruiting both repressive and acti-
vating transcription factors or chromatin remodeling complexes
such as HDACs (Chahrour et al., 2008). Importantly, MBDs like
MeCP2 have different affinities for fully methylated and hemime-
thylated DNA, meaning that the difference between these two
states may actually be a critical component of the methylation
code (Valinluck et al., 2004). In the adult CNS, hydroxymethyla-
tion of cytosines that tag methyl groups for removal can affect
MBD protein binding to DNA (Kriaucionis and Heintz, 2009;
Tahiliani et al., 2009). It is less clear, however, whether hydroxy-
methylation represents a distinct epigenetic marker or an inter-
mediate stage of an existing methylation marker.
What might a DNA methylation code look like? Given that
methylation/demethylationmachinery can produce at least three
different outcomes for each CpG in question (no methylation,816 Neuron 70, June 9, 2011 ª2011 Elsevier Inc.hemimethylation, and full methylation of both DNA strands)
and that the promoter and intragenic regions of a plasticity
genemay contain hundreds of CpG sites, the potential combina-
torial complexity of a DNA methylation code is astounding.
Indeed, it is conceivable that even within a small stretch of
DNA, CpG sites could exhibit any of the three possibilities,
thereby leading to site-specific outcomes (as illustrated in
Figure 2). Therefore, understanding how DNA methylation
contributes to transcriptional efficacy will require examination
of DNA methylation changes at the single nucleotide level. It is
also important to note that the context of DNA methylation—
i.e., where methylation occurs relative to a transcription factor
binding site or transcription start site—may dramatically influ-
ence its potential effect on gene transcription (Klose et al.,
2005; Weber et al., 2007). To date, existing studies have typically
only examined CpG methylation in relatively small stretches of
DNA near gene transcription start sites.
Recent evidence indicates that, like histone modifications,
changes in DNA methylation represent a critical molecular
component of both the formation and maintenance of long-
term memories (Feng et al., 2010; Lubin et al., 2008; Miller
et al., 2008; Miller et al., 2010; Miller and Sweatt, 2007). Interest-
ingly, contextual fear conditioning consequently increases and
decreases methylation of memory-related genes expressed in
the hippocampus, implicating methylation and demethylation
as a molecular mechanism underlying learning and memory
(Day and Sweatt, 2010a; Miller et al., 2010; Miller and Sweatt,
2007). Consistent with the idea that these changes are nec-
essary for memory formation, inhibition of DNMTs within the
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animals, results in impaired expression of contextual fear memo-
ries (Lubin et al., 2008; Miller and Sweatt, 2007). Likewise, DNMT
inhibitors impair the induction of LTP at hippocampal synapses,
providing an important cellular correlate of learning deficits
induced by blocking DNA methylation (Levenson et al., 2006).
Interestingly, DNMT inhibition in the prefrontal cortex impairs
the recall of existing memories but not the formation of new
memories, indicating circuit-specific roles for DNA methylation
in memory formation and maintenance (Miller et al., 2010). One
challenge in interpreting the results of these studies is that the
nucleoside analogs conventionally used to inhibit DNMT activity,
such as zebularine and 5-aza-deoxycytidine, are believed to
require DNA replication to incorporate into DNA and function
as DNMT inhibitors (Szyf, 2009). Therefore, in the largely postmi-
totic brain, the mechanism by which these compounds enter
DNA is less clear, leading to speculation as to whether these
drugs are capable of inhibiting DNA methylation in the adult
CNS (Day and Sweatt, 2010a). To circumvent this problem,
recent studies have employed a distinct DNMT inhibitor,
RG108, which acts at DNMT’s active sites and therefore does
not require DNA replication. Studies have shown that RG108
produces the same deleterious effects on learning and memory
as nucleoside DNMT inhibitors (Lubin et al., 2008; Miller et al.,
2010). Likewise, conditional forebrain- and neuron-specific
deletion of DNMT1 and DNMT3a impairs performance on the
Morris water maze and fear learning (Feng et al., 2010), providing
genetic confirmation of a role for DNMTs in cognition.
Methodological Considerations in Testing the
Epigenetic Hypothesis of Memory
As discussed above, changes in histone modifications and DNA
methylation in the CNS occur in association with memory forma-
tion, while experimental manipulation of DNA and histone meth-
ylation/acetylation can alter memory formation. These findings
strongly support the involvement of an epigenetic code in
processes of learning and memory. However, the vast majority
of the experiments undertaken thus far have not attempted to
directly test the idea that specific patterns of histone and DNA
chemical modifications are translated in a combinatorial fashion
to subserve specific aspects of memory. No doubt, addressing
this defining feature of the epigenetic code is a large undertaking
that requires multiple independent lines of experimentation. In
this section we will briefly comment on a few of the methodolog-
ical challenges in testing the epigenetic code hypothesis,
keeping in mind that defining some of these challenges may
help conceptualize advances designed to overcome them.
To illustrate the critical involvement of an epigenetic code in
memory formation and storage, it will be necessary to experi-
mentally demonstrate that neurons of memory-encoding circuits
generate a combinatorial set of epigenetic marks in response to
a memory-evoking experience. To further substantiate the
‘‘epigenetic code’’ theory, more refined experiments would be
required to show that disrupting this specific combinatorial
pattern, without altering the overall sum of modifications across
the epigenome, suppresses memory function. Moreover, it will
be necessary to illustrate that this combinatorial code occurs
at the level(s) of a single gene or allele, perhaps at a single CpG
island, at an individual chromatin particle, or even at a singlehistone amino-terminal tail. Finally, all contemporary models of
memory storage posit sparse encoding of memories within
a memory circuit, meaning that measuring changes at the level
of individual neurons is a necessary and relevant parameter.
Taken in sum, these considerations present an immense set of
technical hurdles to overcome in order to test the epigenetic
code hypothesis.
Nevertheless, several recent technical advances will likely
aid in more directly testing the epigenetic theory of memory
formation. In particular, modern genetic engineering approaches
now allow single nucleotide mutations to be introduced into the
genome of a mouse that can manifest in single cell types,
restricted to one or a few brain subregions, and temporally
restricted to postdevelopmental time points. A reasonable
number of memory-associated genes are epigenetically modi-
fied in response to experience, including bdnf, reelin, zif268,
PP1, arc, and calcineurin, providing a set of candidates for
the assessment of combinatorial epigenetic changes at the
single-gene or single-exon/intron level using precise genetic
engineering approaches. Moreover, the application of genome-
wide tools to this problem will enable examination of DNA meth-
ylation patterns in a much wider pool of genes, which is currently
lacking. Finally, chromatin immunoprecipitation (ChIP) proce-
dures also allow detection of methyl-DNA binding proteins
and specific histone modifications at the level of these and
other specific gene loci. Additionally, new molecular biological
methods have emerged for identifying changes in DNA methyla-
tion at the single-cell and single-allele level. Bisulfite sequencing,
considered the ‘‘gold standard’’ for assaying DNA methylation,
provides single-nucleotide information about a cytosine’s meth-
ylation state. Global analysis of all DNA from a given brain region
cannot distinguish between DNA methylation changes in dif-
ferent cell types (e.g., neurons versus glial cells, glutamatergic
versus GABAergic cells, etc.), which is a current limitation.
However, bacterial subcloning of single pieces of DNA, which
originate from single alleles within a single cell, allows isolation
of DNA from single CNS cells. Thus, direct bisulfite sequencing
combined with DNA subcloning enables quantitative interroga-
tion of single-allele changes in methylation, at the single nucleo-
tide level, in single cells frombrain tissue (Miller et al., 2010). Such
an approach may be especially powerful for interrogating the
sparsely encoded, environmentally induced neuronal changes
that occur during learning and memory. Overall, these recent
and emerging techniques pave the way for substantive experi-
mental interrogation of experience-driven epigenetic changes,
potentially aiding in the identification of an epigenetic code,
that underliememory formation. The ultimate challenge for future
studieswill be to determine in a comprehensive fashion howDNA
methylation and chromatin remodeling at the single-cell level is
regulated and translated into changes in neural circuit function
and behavior in the context of learning and memory.
The Role of MAPK Signaling in Regulating Epigenetic
Changes
The MAPK cascade was first established as the prototypic regu-
lator of cell division and differentiation in nonneuronal cells (Bad-
ing and Greenberg, 1991; English and Sweatt, 1996; Fiore et al.,
1993; Murphy et al., 1994). The prominent expression and acti-
vation of MAPKs in the mature nervous system, particularly inNeuron 70, June 9, 2011 ª2011 Elsevier Inc. 817
Figure 3. The ERK/MAP Kinase Cascade in the
Hippocampus
The ERK/MAPK cascade can integrate a wide variety of
signals and result in a final common output. The ERK
cascade is initiated by the activation of Raf kinase via the
small GTP-binding protein, ras, or the ras-related protein,
rap-1. Activated Raf then phosphorylates MEK, a dual
specific kinase. MEK phosphorylates ERK 1 and 2 on a
tyrosine and threonine residue. Once activated, ERK
exerts many downstream effects, including the regulation
of cellular excitability and the activation of transcription
factors, leading to altered gene expression. Each MAP
kinase cascade (ERK, JNK, and p38 MAPK) is composed
of three distinct kinases activated in sequence, and
despite the fact that many separate MAP kinase families
exist, there is limited crosstalk between these highly
homologous cascades.Whilemany of the steps of the ERK
cascade have been elucidated, the mechanisms by which
the components of the MAP kinase cascade come into
physical contact have not been investigated. In this
context, it is interesting to note that there are multiple
upstream regulators of ERK in the hippocampus: NE, DA,
nicotinic ACh, muscarinic ACh, histamine, estrogen,
serotonin, BDNF, NMDA receptors, metabotropic gluta-
mate receptors, AMPA receptors, voltage-gated calcium
channels, reactive oxygen species, various PKC isoforms,
PKA, NO, NF1, and multiple ras isoforms and homologs.
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the MAPK cascade in terminally differentiated, nondividing
neurons in the brain (Bading and Greenberg, 1991; English and
Sweatt, 1996). It was speculated that the cascade might have
been co-opted in the mature nervous system to subserve
synaptic plasticity and memory formation, thereby proposing
a mechanism of molecular homology between cellular develop-
ment and learning and memory (Atkins et al., 1998; English and
Sweatt, 1996; English and Sweatt, 1997; Sweatt, 2001).
Since then, there has been a rich literature detailing the impor-
tance of the MAPK in neuronal functions, including plasticity
(Thomas and Huganir, 2004). As a brief example, the first exper-
iments to begin to test the idea that the MAPK cascade is
critical in neuronal processes demonstrated that the extracel-
lular-signal regulated kinase (ERK) isoforms of MAPK are acti-
vated with LTP induction in hippocampal slices, where ERK
activation is necessary for NMDA receptor-dependent LTP in
area CA1 (English and Sweatt, 1996; English and Sweatt,
1997). Subsequent studies showed that ERK is activated in the
hippocampus with associative learning and is necessary for
contextual fear conditioning and spatial learning (Atkins et al.,
1998). Studies from a wide variety of laboratories have now
shown that MAPK signaling cascades are involved in many
forms of synaptic plasticity and learning across many species
(Reissner et al., 2006). Moreover, recent studies from Alcino
Silva’s group have directly implicated misregulation of the ras/
ERK pathway in a human learning disorder, neurofibromatosis-
associated mental retardation (Ehninger et al., 2008). Because
the ERK cascade plays a fundamental role in regulating synaptic
function, elucidating the targets and regulation of ERK is critical
to understanding basic biochemical mechanisms of hippo-
campal synaptic plasticity and memory formation (Ehninger
et al., 2008; Weeber and Sweatt, 2002).
ERK is a pluripotent signaling mechanism, because it
impinges upon targets in the neuronal membrane, in the cyto-
plasm, and within the nucleus in order to effect changes in818 Neuron 70, June 9, 2011 ª2011 Elsevier Inc.synaptic function and connectivity (Figure 3). ERK regulation is
especially complex in the hippocampus: the cascade is down-
stream of a multitude of cell surface receptors and upstream
regulators. The prevailing model is that ERK serves as a
biochemical signal integrator that allows the neuron to decide
whether or not to trigger lasting changes in synaptic strength
(Sweatt, 2001). The canonical role of the ERK pathway in all cells
is regulation of gene expression, and studies of the role of ERK
signaling in synaptic plasticity, memory formation, drug addic-
tion, and circadian rhythms have borne this out in the adult
CNS as well (Girault et al., 2007; Sweatt, 2001; Valjent et al.,
2001). There are several mechanisms through which ERK has
been shown to regulate gene transcription in the CNS (Figure 3).
One regulatory mechanism is transcription factor phosphoryla-
tion, and we and others have shown that ERK is required for
CREB phosphorylation in hippocampal pyramidal neurons
(Eckel-Mahan et al., 2008; Impey et al., 1998; Roberson et al.,
1999; Sindreu et al., 2007). The efficacy of phospho-CREB in
modulation of transcription also depends upon the recruitment
and activation of a number of transcriptional coactivators,
including CBP (Vecsey et al., 2007). Thus, regulation of transcrip-
tion by CREB depends upon the activity of HATs (McManus and
Hendzel, 2001; Ogryzko et al., 1996; Perissi et al., 1999; Yuan
and Gambee, 2001). In addition, histone phosphorylation
contributes to regulating gene transcription, in particular through
Serine 10 phosphorylation of histone H3, which is associated
with transcriptional activation.
ERKMAPKs are also central to controlling histone posttransla-
tional modifications in synaptic plasticity and experience-driven
behavioral changes (Borrelli et al., 2008; Brami-Cherrier et al.,
2009; Levenson et al., 2004; Reul et al., 2009; Swank and Sweatt,
2001). Acetylation of histone H3 in the hippocampus, which is
associated with long-term memory consolidation (Fischer et al.,
2007; Korzus et al., 2004; Levenson et al., 2004; Wood et al.,
2006a), is dependent on the activation of NMDA receptors and
of ERK MAPK (Levenson et al., 2004). Activation of NMDA
Figure 4. Model for ERK-Mediated Regulation of Histone Acetylation and Gene Transcription
Activation of the NMDA subtype of glutamate receptors (NMDARs) and voltage-gated Ca2+ channels leads to influx of Ca2+ and activation of the ras-MEK-ERK
signaling cascade in adult neurons. This leads to activation of CREB-mediated transcription via intermediary actions of RSK2 or the mitogen-stimulated kinase,
MSK. A downstream target of these kinases, CREB, is postulated to facilitate transcription through interaction with CREB-binding protein (CBP) and acetylation
of histones. Additional pathways for regulating chromatin structure in memory include metabotropic glutamate receptor (mGluR) and NMDAR activation of
protein kinase M zeta (PKMzeta) and downstream targeting of NFkappaB signaling in the nucleus. ERK MAPK signaling can also activate this pathway as an
ancillary mechanism for chromatin regulation. Targets of this pathway include the transcription factors c-rel and Elk-1, which can regulate the expression of the
MAPK phosphataseMKP-3, which represents a likely site of negative feedback control of the pathway. SeeMain Text and (Lubin and Sweatt, 2007) for additional
discussion.
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surface receptors also increases acetylation of histone H3, and
these effects are blocked by inhibition of ERK signaling (Brami-
Cherrier et al., 2007; Brami-Cherrier et al., 2009; Levenson
etal., 2004;Reul et al., 2009).Moreover, activationofERK through
either thePKCorPKApathways, biochemical events known to be
involved in long-term memory formation, also increases histone
H3 acetylation (Brami-Cherrier et al., 2007; Brami-Cherrier et al.,
2009; Levenson et al., 2004; Reul et al., 2009). Moreover,
ERK/MAPK signaling also regulates histone phosphorylation,
and changes in hippocampal histone phosphorylation following
fear conditioning are ERK/MAPK dependent (Chwang et al.,
2006; Wood et al., 2006b). Overall, a large body of results indi-
cates that histone-associated heterochromatin undergoes ERK-
dependent regulation and that these histone modifications and
changes in heterochromatin are necessary for hippocampal
LTP and memory formation (Alarco´n et al., 2004; Korzus et al.,
2004; Levenson et al., 2004; Wood et al., 2006a).
Typically, ERK does not directly affect nuclear targets, but
rather acts through intermediary kinases. In a series of experi-
ments, Chwang et al. (2007) investigated the role of mitogen-
and stress-activated protein kinase 1 (MSK1), a nuclear kinase
downstream of ERK, in chromatin remodeling during hippo-
campal-dependent memory formation. Mice lacking MSK1
showed impaired Pavlovian fear conditioning and spatial
learning, as well as a deficiency in histone phosphorylation and
acetylation in the hippocampus after fear training. This studyidentifiedMSK1 as an important regulator of chromatin remodel-
ing in long-term memory, identifying a central signal transduc-
tion pathway in plasticity and memory: the ERK-MSK1-histone
phosphoacetylation pathway (Figure 4).
Overall, studies demonstrating a role for MAPK regulation in
memory formation and in triggering lasting behavioral change
are interesting in two contexts. First, these observations are
consistent with one of the broad themes we are developing in
this review, which is that molecular mechanisms that operate
in cell differentiation and development have been co-opted in
the mature nervous system to subserve lasting functional
changes related to memory formation. In this vein, then, MAPK
signaling and a role for epigenetic mechanisms in memory
provide two prominent examples of molecular homologies
between memory and development. Second, the role of MAPKs
in regulating histone posttranslational modifications in memory
and plasticity provides a direct mechanistic link between epige-
netic modifications and learning and memory, indeed illustrating
a striking conservation of a pluripotent cell-surface-to-epige-
nome signal transduction pathway in cellular development and
cognitive memory.
How Does the Epigenetic Code Manifest Functional
Change?
Integration of Multiple Epigenetic Modifications
As discussed above, it is well understood that certain histone
modifications interact with each other by preventing access toNeuron 70, June 9, 2011 ª2011 Elsevier Inc. 819
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how DNA methylation affects histone modifications and vice
versa. One possibility is that DNA methylation patterns are
established and maintained by specific combinations of chro-
matin modifications. For example, HDACs are known to interact
with DNMTs, whereas transcription factors that recruit HAT
enzymes can trigger demethylation of DNA (D’Alessio and
Szyf, 2006; D’Alessio et al., 2007). Likewise, HDAC inhibitors
are capable of inducing DNA demethylation (Cervoni and Szyf,
2001; Szyf, 2009).
Conversely, it is also possible that DNA methylation regulates
important aspects of chromatin state, indicating a bidirectional
relationship between histone and DNAmodifications. Consistent
with this hypothesis, MeCP2, which binds preferentially to fully
methylated DNA, can associate with both HDAC machinery
and histone methyltransferases to alter specific histone modifi-
cations (Bird, 2002; Fuks et al., 2003a; Fuks et al., 2003b).
Additionally, DNMT inhibitors block changes in H3 acetylation
associated with memory formation (Miller et al., 2008). Further-
more, deficits in memory and hippocampal synaptic plasticity
induced by DNMT inhibitors can be reversed by pretreatment
with an HDAC inhibitor (Miller et al., 2008). Taken together, these
results reveal a complex relationship between histone modifica-
tions and DNA methylation and suggest that simple consider-
ations of a ‘‘histone code’’ or ‘‘DNA methylation code’’ will
each be inadequate in terms of predicting transcriptional output.
The interactions between the two mechanisms need to be fully
understood in order to formulate a more comprehensive epige-
netic code hypothesis for transcriptional regulation in memory.
Regulation of Gene Expression
To produce a diverse array of cell classes despite working with
identical underlying genetic material, cells must be capable of
expressing or repressing a given set of genes to generate
a neuron, a hepatocyte, or a hematocyte. These complex gene
transcription programs initiated during cellular differentiation
and division appear to be epigenetically regulated (Ng and
Gurdon, 2008) and ultimately ensure that a given cell lineage
can bemaintained throughmultiple rounds of cell division or pro-
longed life in the case of nondividing cells.
Similarly, many types of long-lasting synaptic plasticity such
as LTP, required for memory consolidation, initiate complex
gene transcription programs (Alberini, 2008; Davis and Squire,
1984; Frey et al., 1988). In fact, activity-dependent changes in
gene expression have long been implicated in learning and
memory processes in the CNS (Flavell and Greenberg, 2008;
Loebrich and Nedivi, 2009). Therefore, epigenetic modifications
may play a similar role in the CNS, initiating functional conse-
quences within a cell or a circuit by modulating gene expression.
Accumulating evidence already supports the hypothesis that
gene expression programs are a functional readout of epigenetic
marking in the CNS in memory formation. As reviewed above,
these gene programs are largely dependent on intracellular
signaling cascades (such as the MAPK pathway) and activation
of critical transcription factors that bind to specific sequences in
gene promoter regions. Indeed, it may be this specificity in tran-
scription factor binding sites that leads certain signal transduc-
tion cascades to target specific genes and induce specific
epigenetic changes. For example, when phosphorylated,820 Neuron 70, June 9, 2011 ª2011 Elsevier Inc.CREB binds to cAMP responsive element sites in gene pro-
moters and interacts with CBP, which possesses HAT activity
(Gonzalez et al., 1989; Montminy et al., 1990a; Montminy et al.,
1990b; Silva et al., 1998). Interestingly, stimuli that produce
long-lasting LTP also increase CREB phosphorylation in the
hippocampus (Deisseroth et al., 1996), and CREBmanipulations
impair memory formation in multiple tasks (Silva et al., 1998).
Likewise, blocking cAMP-dependent transcription alone is suffi-
cient to impair LTP maintenance (Frey et al., 1993; Impey et al.,
1996). Thus, given that transcriptional machinery such as
CREB has long been established as a regulator of cellular and
behavioral memory (Frank and Greenberg, 1994; Shaywitz and
Greenberg, 1999; Silva et al., 1998), it is perhaps not surprising
that epigenetic modifications have been found to interact with
these systems (Chahrour et al., 2008; Renthal andNestler, 2008).
Other epigenetic targets have also been identified in regulating
overall transcription rates of specific genes in the establishment,
consolidation, and maintenance of behavioral memories (Guan
et al., 2009; Lubin et al., 2008; Miller et al., 2008; Miller et al.,
2010; Peleg et al., 2010). Specifically, contextual fear condi-
tioning induces a rapid but reversible methylation of the memory
suppressor gene PP1 within the hippocampus and demethyla-
tion of reelin, a gene involved in cellular plasticity and memory
(Miller and Sweatt, 2007). Importantly, each of these DNA meth-
ylation changes are functionally relevant, leading to decreased
expression of PP1 and increased expression of reelin (Miller
and Sweatt, 2007). Moreover, consistent with the finding that
blocking DNA methylation in the anterior cingulate cortex pre-
vents remote memory maintenance, another study reported
long-lasting changes in methylation of the memory suppressor
gene calcineurin within this brain area following contextual fear
conditioning (Miller et al., 2010). These changes in calcineurin
methylation persisted at least 30 days following conditioning,
suggesting the change is stable enough to maintain a memory
over time despite ongoing cellular activity and molecular turn-
over. Thus, calcineurin is an excellent candidate for a molecular
storage device. Likewise, although they are too numerous to
name here, histone modifications have been repeatedly associ-
ated with changes in gene transcription and expression in
multiple organisms, systems, and brain subregions (Brami-Cher-
rier et al., 2005; Dulac, 2010; Guan et al., 2002; Gupta et al.,
2010; Koshibu et al., 2009; Renthal and Nestler, 2008). Thus,
these results reveal that even within nondividing neurons in the
adult CNS, epigenetic mechanisms regulate patterns of gene
expression in a functionally relevant manner. Indeed, when
viewed through this lens, epigenetic changes can simply be
viewed as one of the final steps (or perhaps the final step) in
a long cascade of events that leads to learning-related gene
transcription (Kornhauser et al., 2002; Shaywitz and Greenberg,
1999; Sweatt, 2001).
Alternative Splicing
A related means for epigenetic control of gene expression
involves the unique regulation of specific protein isoforms, or
differently spliced versions of the same protein. This can occur
in multiple ways, such as increased expression of one exon
over another competing exon or silencing of an entire exon. By
regulating the expression of splice variants with different cellular
functions or different affinities for effector proteins, the potential
Neuron
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fashion (Nilsen and Graveley, 2010).
The mechanisms that regulate alternative splicing are
currently unclear. However, histone modifications appear to
modulate this process by recruiting different splicing regulators
that determine splicing outcome (Luco et al., 2010). DNA meth-
ylation is also likely involved in the differential expression of
BDNF exons following fear learning (Lubin et al., 2008). Contex-
tual fear conditioning produces a rapid increase in mRNA for
BDNF exon IV, thereby decreasing methylation at this locus in
area CA1 of the hippocampus. Interestingly, context exposure
alone (no conditioning) produced increases in BDNF exon I
and VI mRNA, which also corresponded to decreased CpG
methylation at these sites.Moreover, intrahippocampal infusions
of the DNMT inhibitors zebularine or RG108 impaired fear
memory expression, despite the fact that they increase expres-
sion of all BDNF exons in naive animals. Importantly, the same
study reported that in animals that underwent contextual fear
conditioning, zebularine blocked the learning-related decreases
in BDNF exon IV methylation. Together, these results reveal that
DNAmethylation regulates expression of BDNF splice variants in
a complex, experience-dependent manner and that the effects
of DNMT inhibitors likely depend on the overall behavioral and
cellular context. Experience-dependent regulation of BDNF iso-
forms by DNA methylation represents the clearest evidence of
a CpG methylation ‘‘code’’ in the formation and consolidation
of behavioral memories.
Imprinting and Allelic Tagging
Adult fully differentiated cells in placental mammals canmanifest
differential handling of paternal and maternal copies of somatic
genes, a phenomenon referred to as imprinting. Thus, specific
genes expressed in nongermline cells including neurons, which
are not on the X or Y chromosome, can be ‘‘imprinted’’ with
DNA methylation. These imprinting marks cross the generations
through the germline and designate a particular copy (allele) of
a gene as having originated with the mother versus the father.
In traditional cases of genetic imprinting, one copy of the gene
is fully silenced, leaving one parent’s copy of the gene the
exclusive source of cellular mRNA product.
One prominent example of an imprinted gene involved in
cognition is ube3a, which encodes ubiquitin E3 ligase. Imprinted
(i.e., methylated) alleles of the ube3a gene are preferentially
expressed in a brain subregion-specific fashion; for example,
thematernal copy is selectively expressed in neurons in the cere-
bellum and forebrain, including the hippocampus (Jiang et al.,
1998). Mutations in the maternal copy of the ube3a gene result
in Angelman syndrome, a disability characterized by autism-
like symptoms accompanied with severe learning and memory
deficits and a near complete absence of speech learning.
Studies of Angelman syndrome were the first to implicate the
epigenetic mechanism of imprinting in learning, memory, and
synaptic plasticity (Jiang et al., 1998). Notably, mice with a
maternal deficiency in UBE3A function display deficits in hippo-
campal-dependent learning and memory and a loss of hippo-
campal long-term potentiation at Schaffer/collateral synapses
(Jiang et al., 1998).
For many years, imprinting of genes in the adult CNS was
assumed to be restricted to a few genes, 30–50 or so beinga common assumption. However, gene imprinting has recently
been found to occur at much higher levels than this: a recent
pair of exciting papers from Catherine Dulac’s laboratory have
greatly expanded our view of the importance of gene imprinting
in CNS function in the adult nervous system (Gregg et al., 2010a;
Gregg et al., 2010b). This work from Dulac and colleagues
demonstrated that over 1300 gene loci in the adult CNSmanifest
differential read-out of the paternal versus maternal allele. Many
of these differentially regulated genes also exhibited brain subre-
gion-selective expression as well. These findings identify par-
ental expression bias as a major mode of epigenetic regulation
in the adult CNS, and one important implication of these studies
is that epigenetic control of the expression of parent-specific
alleles is a driving factor for regulating gene transcription broadly
in the brain.
The control of the specific expression of one parental allele
over another through imprinting of genes in the mature CNS
may greatly increase the complexity and subtlety of transcrip-
tional control that operates in cognition. The traditional view of
imprinting assumes all-or-none silencing of one allele, rather
than a partial expression bias. The work of Dulac and colleagues
may necessitate a redefinition of imprinting to incorporate the
concept of widespread partial attenuation of one allele, where
paternal and maternal alleles are differentially handled and ex-
pressed. The function of these genetic parent-of-origin effects
may be ‘‘allelic tagging’’ of specific copies of a gene within
a neuron (Day and Sweatt, 2010b). By this mechanism, one allele
of a gene (e.g., the paternal copy) could be modified separately
from the other allele, providing two templates of the same gene in
the same cell that can be differentially regulated by plasticity-
related epigeneticmechanisms. Differential epigenetic modifica-
tion of the two available copies of a given genewithin a cell would
allow each allele to be handled and expressed differently across
the life span. As a speculative example for illustrative purposes,
a tagged paternal allele of the BDNF gene in a single neuron
might be used exclusively during development and epigeneti-
cally regulated as appropriate for its role during early life. The
maternal BDNF allele might then be reserved for use in the adult,
wherein memory-associated epigenetic mechanisms might
operate upon a fresh template of the gene as necessary for
triggering short- or long-term activity-dependent changes in
BDNF transcription. Epigenetic imprinting of the parental versus
maternal alleles would be a prerequisite for this sort of differential
epigenetic handling.
Epigenetically Based Disorders of Cognition and Novel
Therapeutic Targets
Epigenetic mechanisms of pathogenesis have been implicated
in several CNS diseases, including neurodevelopmental disor-
ders of cognition in which disruptions in learning and memory
are the primary clinical sequelae. Disorders in this category are
Angelman syndrome and Rubinstein-Taybi syndrome, fragile X
mental retardation (FMR), and Rett syndrome. In addition, recent
work has implicated derangement of epigenetic mechanisms in
postdevelopmental neurodegenerative disorders of aging such
as Alzheimer’s disease and neuropsychiatric conditions such
as drug addiction. Given the protracted and often devastating
nature of these disorders, drugs that target the underlyingNeuron 70, June 9, 2011 ª2011 Elsevier Inc. 821
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apeutic avenues.
In this section we discuss recent exciting findings that explore
the manipulation of epigenetic modifications as a therapeutic
avenue for the treatment of cognitive dysfunction. We then
describe Rett syndrome as one of the best-established epige-
netic disorders specifically dependent on DNA methylation.
Finally, we address the emerging role of epigenetic mechanisms
in substance abuse and drug addiction.
Histone Acetylation and HDAC Inhibitors
A promising avenue for therapeutic intervention involves the use
of drugs that target HDAC proteins to prevent the removal of
acetyl groups on histone tails (Kazantsev and Thompson,
2008; Szyf, 2009). This class of drug, which includes trichostatin
A (TSA), suberoylanilide hydroxamic acid (SAHA), and sodium
butyrate, inhibit several isoforms of HDAC enzymes and result
in global histone hyperacetylation. A number of these drugs
have already been approved for clinical use in patients or are
currently in clinical trials in the cancer arena (Szyf, 2009). As dis-
cussed above, histone acetylation is robustly associated with
‘‘activated’’ gene transcription, and the formation of new memo-
ries produces increases in histone acetylation in the hippo-
campus (Peleg et al., 2010). In this context, treatment with
HDAC inhibitors has been shown to improve memory formation
in hippocampal-dependent tasks and enhance hippocampal
LTP (Levenson et al., 2004). Moreover, HDAC inhibitors have
been shown to selectively reverse deficits in histone acetylation
in aged animals, effectively restoring the ability to learn new
associations (Peleg et al., 2010). Finally, even after the induction
of severe neuronal atrophy, HDAC inhibitors restore memory
formation and even enable access to previously formed long-
term memories (Fischer et al., 2007). This result is especially
exciting given that a number of patients who present with
dementia or Alzheimer’s disease have difficulty retrieving previ-
ously formed memories (American Psychological Association,
2000).
Importantly, the memory-enhancing effects of HDAC inhibi-
tors may be mediated by specific HDAC isoforms. Selective
overexpression of HDAC2 in neurons produces a decrease in
spine density and impairs synaptic plasticity andmemory forma-
tion, whereas overexpression of HDAC1 had little effect (Guan
et al., 2009). Likewise, deficiency in HDAC2 or chronic treatment
with HDAC inhibitors resulted in increased spine density and
improved memory function (Guan et al., 2009). In contrast,
another study indicated that systemic inhibition of HDACs (and
specifically class 1 HDACs) dramatically improved contextual
memory function in a mouse model of Alzheimer’s disease
(Kilgore et al., 2010). Thus, future research will be required to
parse the effects of HDAC inhibitors on memory function in
normal, aged, and diseased mouse models. Nevertheless, the
use of HDAC inhibitors in the treatment of learning and memory
disorders or neurodegenerative diseases possesses clear thera-
peutic potential.
Histone Methylation
Histone methylation and demethylation represent a second set
of modifications that may possess therapeutic interest in relation
to disorders of learning and memory. However, unlike histone
acetylation, histone methylation is not universally associated822 Neuron 70, June 9, 2011 ª2011 Elsevier Inc.with either transcriptional repression or transcriptional activation
(Ng et al., 2003; Scharf and Imhof, 2010). Instead, certain modi-
fications, such as dimethylation at H3K9, are associated with
transcriptional repression, whereas other modifications, such
as dimethylation or trimethylation of H3K4, are associated with
transcriptional activation (Scharf and Imhof, 2010; Wang et al.,
2008). However, there are a number of relatively selective
compounds capable of modifying specific methylation marks
(Allis et al., 2007; Greiner et al., 2005; Scharf and Imhof, 2010;
Shi and Whetstine, 2007; Szyf, 2009), such as the small-mole-
cule inhibitor of the G9a methyltransferase, which reverses
H3K9 dimethylation (Kubicek et al., 2007). In rodents, fore-
brain-specific deletion of the GLP/G9a histone methyltransfer-
ase complex results in a number of learning-related behavioral
deficits, in part by enabling the expression on nonneuronal genes
(Schaefer et al., 2009). Similarly, mice with a heterozygous dele-
tion ofMll, an H3K4-specific methyltransferase, exhibited signif-
icant impairment in the formation of long-term contextual (but
not cued) fear memories (Gupta et al., 2010). Thus, although
the therapeutic potential of histone methylation modifying
enzymes is relatively unexplored at the present time, these
results indicate that selective antagonists of H3K4 demethylating
enzymes may be interesting candidates for treating learning and
memory disorders (Shi et al., 2004).
DNA Methylation and Cognitive Dysfunction: Insights
from Rett Syndrome
Rett syndrome is a disorder that affects around 1 in 10,000 to
15,000 females. Typically, females with Rett syndrome appear
developmentally normal until between 6 and 18 months of
age, at which time development stagnates and subsequently
regresses. Classic Rett syndrome is characterized by profound
cognitive impairment, communication dysfunction, stereotypic
movements, and pervasive growth failure (Wan et al., 1999). In
a breakthrough discovery, mutations in the gene encoding
MeCP2 were found to be responsible for at least 95% of classic
Rett syndrome cases (Amir et al., 1999). This seminal finding
provided a link between DNA methylation, specifically involving
the methyl-DNA binding protein MeCP2, and intellectual
dysfunction.
The identification of mecp2 as the mutated gene in Rett
syndrome led to the creation of several transgenic mouse
models of Rett syndrome. Initial attempts to create MeCP2 null
mice resulted in embryonic lethality (Tate et al., 1996). To circum-
vent this problem, two groups independently used the Cre/LoxP
recombination system to delete portions of the MeCP2 gene.
The Jaenisch laboratory used a targeted construct that deleted
exon 3, which encodes for most of the MBD, while the Bird lab
deleted exons 3 and 4, which encode for all but the first 8 amino
acids of the protein (Chen et al., 2001; Guy et al., 2001). MeCP2
null mice from the Jaenisch and Bird laboratories have impair-
ments in hippocampal physiology and behavior, as well as
a number of more general physical deficits, including early
postnatal lethality. Symptomatic male mice have altered hippo-
campal NMDA receptor expression and impairments in LTP
and LTD (Asaka et al., 2006). Male mutant mice also display defi-
cits in cued fear conditioning, while mutant mice of both sexes
display deficits in object recognition and altered anxiety (Stearns
et al., 2007).
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laboratories display an early onset of symptoms and short life
span that differentiates them from classic Rett syndrome and
limits the analysis of symptoms. Two groups have developed
models that attempted to address these limitations. The Zoghbi
group generated the mutant mouse model MeCP2308/Y, pos-
sessing a premature stop after codon 308, where mutations
have been frequently indentified in humans with Rett syndrome.
Thesemice exhibit a milder phenotype, presumably because the
truncated protein retains partial function, characterized by
impaired motor function, reduced activity, stereotypic forelimb-
clasping movement, and abnormal social interactions (Moretti
et al., 2005). MeCP2308/Y mice also display impaired LTP,
increased basal synaptic transmission, and deficits in the induc-
tion of LTD, as well as corresponding disruptions in spatial
memory, contextual fear conditioning, and long-term social
memory (Moretti et al., 2006). Importantly, these mice possess
hyperacetylation of H3 (Shahbazian et al., 2002). The Tam group
generated another line of MeCP2 null mice (Mecp2tm1Tam) with
a deletion of the methyl-binding domain. Behavioral testing of
these mice revealed deficits in cerebellar learning and impair-
ments in both cued and contextual fear conditioning and contex-
tual association (Pelka et al., 2006). In a collaborative effort, the
Zoghbi and Sweatt laboratories showed that MeCP2-deficient
animals have deficits in spatial learning, contextual fear condi-
tioning, and LTP deficits (Moretti et al., 2006). Moreover, they
also showed that overexpression of MeCP2 resulted in en-
hanced fear conditioning and enhanced LTP (Collins et al.,
2004). Since Rett syndrome is caused by mutations in MeCP2,
enhancing MeCP2 levels could therefore be a therapeutic
option. Overall, these findings strongly support the idea that
MeCP2 might be involved in regulation of LTP and hippo-
campal-dependent memory formation.
Rett syndromehas classically been viewedas aneurodevelop-
mental disorder, the underlying genetic basis of which is muta-
tion/deletion of the MeCP2 gene and resultant disruption of
normal MeCP2 function during prenatal and early postnatal
development. This model is consistent with the fact that the
mutated gene product is present throughout development.
However, the mutant gene product is also present in the fully
developed adult CNS. Thus, it is unclear whether Rett syndrome
is caused exclusively by disruption of MeCP2 function during
development, or whether loss of MeCP2 in the mature CNS
might also contribute to neurobehavioral and cognitive dysfunc-
tion in Rett patients. Recent data from Adrian Bird’s group has
suggested that loss of normal MeCP2 function in the adult
nervous system contributes to neurobehavioral dysfunction in
Rett syndrome. Specifically, inducible expression of MeCP2 in
adult animals extensively rescued the neurological phenotypes
in MeCP2-deficient animals. Moreover, exciting work from
Greenberg and colleagues has revealed activity-dependent
acute regulation of MeCP2 function in neurons, specifically
through phosphorylation of specific serine residues (Chen
et al., 2003; Tao et al., 2009; Zhou et al., 2006). These and other
recent findings (Deng et al., 2010) strongly suggest a dynamic
role for MeCP2 in the adult CNS in the regulation of activity-
dependent gene transcription during learning and memory.
Therefore, MeCP2 function may be necessary in an ongoingfashion for normal learning and memory and synaptic plasticity
in the mature CNS. A new understanding of the role of MeCP2
in the adult CNSmight allow the development of new therapeutic
approaches to Rett treatment based on restoration or augmen-
tation of MeCP2 function after CNS development is largely
completed. Findings from studies of Rett syndrome patients
and genetically engineered mouse models implicate DNA meth-
ylation as a central regulator of adult memory formation. That
animals deficient in methyl-DNA binding proteins have deficits
in memory and long-term synaptic plasticity is in line with this
conceptual framework. Finally, these observations are consis-
tent with the overall theme we are developing in this review,
which is the co-opting of developmental molecular mechanisms
to subserve long-lasting functional changes in the adult CNS.
Epigenetic Modifications and Maladaptive Behaviors:
Insights from Drug Addiction
Drug addiction is a chronic, relapsing disorder in which drug-
related associations (e.g., discrete drug cues, locations in which
drugs were consumed, and drug paraphernalia) are capable of
exerting tremendous control over behavior long after drug taking
has ceased. On this basis, drug addiction has long been consid-
ered and interpreted as a disorder of learning and memory
(Berke and Hyman, 2000; Hyman, 2005; Hyman et al., 2006;
Kelley, 2004). A hallmark feature of drugs of abuse is that they
result in persistent functional and structural alterations in brain
reward circuits such as the nucleus accumbens (LaPlant et al.,
2010; Nestler, 2001; Robinson and Kolb, 1997). These changes
occur alongside equally long-lasting changes in expression of
genes such as DFosB, BDNF, and creb (Kumar et al., 2005;
McClung and Nestler, 2003; Nestler, 2001), leading to the
suggestion that epigenetic mechanisms may be critical compo-
nents of drug-related responses (Nestler, 2001). A number of
pioneering reports by Eric Nestler and colleagues have largely
confirmed this hypothesis, revealing that epigenetic mecha-
nisms are involved in both biochemical and behavioral
responses to drugs of abuse. The first of these studies employed
a chromatin immunoprecipitation approach to identify histone
modifications at individual gene-targets in the nucleus accum-
bens following cocaine treatment (Kumar et al., 2005). This tech-
nique revealed that acute cocaine administration produced
a dynamic increase in phosphoacetylation at H3 (S10/K14) and
increased acetylation on H4, both surrounding the promoter
region of c-fos, an immediate early gene. In contrast, prolonged
cocaine exposure produced an increase in acetylation at H3K9
and H3K14 at the promoter for FosB, BDNF, and Cdk5 genes,
while leaving c-fos unchanged. This is critical given that FosB
and BDNF have been implicated in the transition from casual
to chronic drug use and cocaine craving during withdrawal,
respectively (Grimm et al., 2003; McClung and Nestler, 2003).
Interestingly, the increase in H3 acetylation at the BDNF gene
persists for at least a week following cessation of cocaine, which
overlaps with the withdrawal-related increases in BDNF levels
across multiple brain regions (Grimm et al., 2003).
Further experiments have demonstrated that these modifica-
tions are important regulators of the rewarding properties of
cocaine. Treatment with an HDAC inhibitor prior to cocaine or
morphine exposure enhances behavioral preferences for places
associated with drug delivery (so-called conditioned placeNeuron 70, June 9, 2011 ª2011 Elsevier Inc. 823
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Sanchis-Segura et al., 2009). Additionally, antagonism of sirtuins
(Sirt1 and Sirt2, a unique class of HDACs) in the nucleus accum-
bens reduces CPP and operant responding for cocaine reward
(Renthal et al., 2009). In contrast, overexpression of HDAC4 in
the nucleus accumbens impairs the development of a condi-
tioned place preference for cocaine and decreases the break
point for cocaine self-administration, indicative of blunted moti-
vation to consume the drug (Kumar et al., 2005; Wang et al.,
2010). Similarly, viral overexpression of HDAC5 in the nucleus
accumbens blunts the development of cocaine CPP, whereas
global deletion of the HDAC5 gene enhances CPP (Renthal
et al., 2007). Conversely, a recent report found that HDAC inhib-
itors delivered during extinction sessions facilitate the extinction
of cocaine CPP in mice, indicating that histone acetylation may
also play a critical role in the reversal of drug-related memories
(Malvaez et al., 2010). Together, these findings suggest that
HDAC inhibitors facilitate learning and memory, whether it is
during associative conditioning or extinction. Therefore, HDACs
may be promising candidates for drug abuse treatments, espe-
cially when combined with behavioral therapy.
Although the majority of experiments have focused on histone
acetylation, it is now abundantly clear that other histone modi-
fications, including phosphorylation and methylation, are critical
components of the epigenetic response to drugs of abuse
(Maze et al., 2010; Stipanovich et al., 2008). Indeed, cocaine
induces a robust phosphorylation of H3S10 within the nucleus
accumbens at the promoters of c-fos and c-jun (Brami-Cherrier
et al., 2009). Importantly, this response is regulatedby twodistinct
signal transduction cascades, both of which are downstream of
a major target of drug-induced increases in striatal dopamine
concentration: the activation of dopamine D1 receptors in the
striatonigral (direct) pathway.H3S10phosphorylation is positively
regulated by the same MAPK pathways reviewed above,
includingphosphorylationof ERKandMSK-1-inducedphosphor-
ylation of H3 (Bertran-Gonzalez et al., 2008; Brami-Cherrier et al.,
2005). Likewise, nuclear accumulation of 32 kDa dopamine and
cyclic-AMP-regulated phosphoprotein (DARPP-32), which also
occurs following D1 receptor activation, acts to inhibit PP1,
thereby preventing histone dephosphorylation (Stipanovich
et al., 2008). Critically, thesepathwaysare instrumental in control-
ling behavioral responses to cocaine and morphine, as inhibition
of D1 receptors, ERK, DARPP-32, and MSK-1, all diminish drug-
induced locomotor responses or drug CPP (Brami-Cherrier et al.,
2009; Brami-Cherrier et al., 2005; Stipanovich et al., 2008).
Much like the emergent evidence that DNA methylation regu-
lates hippocampal-dependent memory formation, recent reports
have revealed that DNA methylation in the striatum is associated
with drug-related behaviors. For example, acute cocaine admin-
istrationproduces rapidchanges in expressionofDNMT isoforms
within the nucleus accumbens (Anier et al., 2010; LaPlant et al.,
2010), suggesting dynamic control of DNA methylation by drugs
of abuse. Consistent with this observation, cocaine produces
a hypermethylation at the promoter region of PP1c (the catalytic
subunit of PP1) in the nucleus accumbens, resulting in enhanced
MeCP2 binding to the PP1c promoter (Anier et al., 2010). Con-
versely, cocaine decreases methylation at the FosB promoter,
which coincides with the transcriptional upregulation of FosB824 Neuron 70, June 9, 2011 ª2011 Elsevier Inc.and is consistent with the observed decrease in MeCP2 binding
to FosB (Anier et al., 2010). Importantly, systemic inhibition of
DNAmethyltransferase activity significantly impairs the develop-
ment of locomotor sensitization induced by repeated cocaine
administration (Anier et al., 2010), and site-specific DNMT inhibi-
tion in the nucleus accumbens boosts the development of
cocaine CPP (LaPlant et al., 2010). In contrast, overexpression
of the DNMT3a isoform within the nucleus accumbens disrupts
cocaine CPP (LaPlant et al., 2010), whereas MeCP2 knockdown
in the dorsal striatum prevents escalation of cocaine self-admin-
istration during extended access (Im et al., 2010). Additionally,
DNA methylation within the hippocampus and prelimbic cortex
is also necessary for the establishment and maintenance of
cocaine CPP, respectively, indicating that epigenetic changes
in brain regions outside of the striatum are also key regulators
of drug memories (Han et al., 2010). These results reveal that
DNA methylation within the striatum is an important biochemical
step in the short- and long-term behavioral response to drugs of
abuse and suggest that interfering with methylation machinery
may constitute a possible avenue for therapeutic treatment.
However, it is important to note here that epigeneticmechanisms
likely do not exist to solely support the formation and persistence
of drug-related memories. Indeed, the same biochemical path-
ways that regulate epigenetic modifications are involved in
unlearned and learned responses to natural rewards like food,
mating, and social interaction (Aragona et al., 2003; Aragona
et al., 2006; Aragona and Wang, 2007; Bureau et al., 2010; Day,
2008; Kelley and Berridge, 2002; Kelley et al., 1997; Shiflett
et al., 2008; Shiflett et al., 2009; Stipanovich et al., 2008). There-
fore, future studies will be required to determine whether these
events also induce epigenetic changes and in what ways these
changes differ from those induced by drug exposure.
Although drug taking is remarkably conserved across species,
it is clear that not all members of a population will exhibit signs of
addiction (e.g., inability to cease drug taking, high motivation to
take the drug, and continued drug use in spite of harmful conse-
quences), despite equivalent drug availability or drug history
(Deroche-Gamonet et al., 2004; Kreek et al., 2005). Therefore,
a critical component in the development of drug addiction is
individual variability. While genetic polymorphisms resulting in
differences in risk taking and drug effects may help to account
for this difference, only 30%–60% of addiction vulnerability is
thought to be heritable in the strict genomic sense (Kreek
et al., 2005). Another potential explanatory factor for vulnerability
to addictive disease are the long-lasting epigenetic effects of
early life experiences or even transgenerational epigenetic inher-
itance (Champagne and Curley, 2009; Roth et al., 2009; Weaver
et al., 2004; Weaver et al., 2005), which is capable of stochastic
variation at a much higher rate than mutation of DNA bases (Pet-
ronis, 2010). Thus, in addition to potentially explaining how drugs
of abuse produce long-lasting changes in neuronal plasticity,
epigenetic mechanisms hold tremendous potential to reveal
why some individuals are more prone to take drugs and/or
develop full-blown addiction.
Conclusions
In writing this review, we have endeavored to provide an over-
view of an emerging topic at the cross-section of developmental
Neuron
Reviewbiology and cognitive neuroscience. We have attempted to
provide a novel synthesis of ideas across modalities of epige-
netic modification and cellular and behavioral processes of
learning and memory. There are interesting and compelling
new avenues of inquiry, such as potential novel therapeutics,
that arise from recent work implicating both DNA methylation
and histone regulation as critical molecular mechanisms under-
lying memory consolidation and memory storage in the adult
CNS. In a broader sense, these findings have established behav-
ioral epigenetics as a subfield in its own right.
Finally, the main overarching theme of this review is that cell
‘‘developmental’’ molecular mechanisms, e.g., growth factor
regulation, MAPK signaling, and epigenetic mechanisms, are
conserved in the adult CNS to subserve long-term plasticity
and memory formation (Ehninger et al., 2008; Marcus et al.,
1994; Weeber and Sweatt, 2002). That cellular development
and adult memory are molecular homologs, i.e., share identical
molecular and biochemical mechanisms, provides an explana-
tion for one of the long-standing questions in neuroscience:
why can’t neurons divide? One of the critical roles for most adult
neurons is to be plastic: to be able tomodulate their function over
time. Moreover, in many instances the cellular changes need to
be either long-lasting or permanent in order for the neuron to
serve the appropriate function in a given neural circuit. The termi-
nally differentiated adult neuron has adaptedmany of the molec-
ular mechanisms used to regulate cell division and perpetuate
cell phenotype in order to perform one of its primary functions,
long-term plasticity. These processes can therefore no longer
be utilized to trigger cell division or alter cell phenotype.
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